TY - JOUR
T1 - Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions
AU - behalf of the Canadian Kidney Knowledge Translation and Generation Network (CANN-NET)
AU - Sood, Manish M.
AU - Manns, Braden
AU - Dart, Allison
AU - Hiebert, Brett
AU - Kappel, Joanne
AU - Komenda, Paul
AU - Molzahn, Anita
AU - Naimark, David
AU - Nessim, Sharon
AU - Rigatto, Claudio
AU - Soroka, Steven
AU - Zappitelli, Michael
AU - Tangri, Navdeep
N1 - Publisher Copyright:
© 2014 by the American Society of Nephrology.
PY - 2014
Y1 - 2014
N2 - Background and objectives The relative influence of facilities and regions on the timing of dialysis initiation remains unknown. The purpose of the study is to determine the variation in eGFR at dialysis initiation across dialysis facilities and geographic regions in Canada after accounting for patient-level factors (case mix). Design, setting, participants, & measurements In total, 33,263 dialysis patients with an eGFR measure at dialysis initiation between January of 2001 and December of 2010 representing 63 dialysis facilities and 14 geographic regions were included in the study. Multilevel models and intraclass correlation coefficients were used to evaluate the variation in timing of dialysis initiation by eGFR at the patient, facility, and geographic levels. Results The proportion initiating dialysiswith an eGFR≥10.5 ml/min per 1.73m2was 35.3%, varying from20.1% to 57.2% across geographic regions and from 10% to 67% across facilities. In an unadjusted, intercept-only linear model, 90.7%, 6.6%, and 2.7% of the explained variability were attributable to patient, facility, and geography, respectively. After adjustment for patient and facility factors, 96.9% of the explained variability was attributable to patient casemix, 3.1%was attributable to the facility, and 0.0%was attributable to the geographic region. These findingswere consistentwhen the eGFRwas categorized as a binary variable (≥10.5 ml/min per 1.73m2) or in an analysis limited to patients with >3 months of predialysis care. Conclusions Patient characteristics accounted for the majority of the explained variation regarding the eGFR at the initiation of dialysis. There was a small amount of variation at the facility level and no variation among geographic regions that was independent of patient- and facility-level factors.
AB - Background and objectives The relative influence of facilities and regions on the timing of dialysis initiation remains unknown. The purpose of the study is to determine the variation in eGFR at dialysis initiation across dialysis facilities and geographic regions in Canada after accounting for patient-level factors (case mix). Design, setting, participants, & measurements In total, 33,263 dialysis patients with an eGFR measure at dialysis initiation between January of 2001 and December of 2010 representing 63 dialysis facilities and 14 geographic regions were included in the study. Multilevel models and intraclass correlation coefficients were used to evaluate the variation in timing of dialysis initiation by eGFR at the patient, facility, and geographic levels. Results The proportion initiating dialysiswith an eGFR≥10.5 ml/min per 1.73m2was 35.3%, varying from20.1% to 57.2% across geographic regions and from 10% to 67% across facilities. In an unadjusted, intercept-only linear model, 90.7%, 6.6%, and 2.7% of the explained variability were attributable to patient, facility, and geography, respectively. After adjustment for patient and facility factors, 96.9% of the explained variability was attributable to patient casemix, 3.1%was attributable to the facility, and 0.0%was attributable to the geographic region. These findingswere consistentwhen the eGFRwas categorized as a binary variable (≥10.5 ml/min per 1.73m2) or in an analysis limited to patients with >3 months of predialysis care. Conclusions Patient characteristics accounted for the majority of the explained variation regarding the eGFR at the initiation of dialysis. There was a small amount of variation at the facility level and no variation among geographic regions that was independent of patient- and facility-level factors.
UR - http://www.scopus.com/inward/record.url?scp=84923807969&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923807969&partnerID=8YFLogxK
U2 - 10.2215/CJN.12321213
DO - 10.2215/CJN.12321213
M3 - Article
C2 - 25248743
AN - SCOPUS:84923807969
SN - 1555-9041
VL - 9
SP - 1747
EP - 1756
JO - Clinical journal of the American Society of Nephrology : CJASN
JF - Clinical journal of the American Society of Nephrology : CJASN
IS - 10
ER -